QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chang, W. Articles by Bulinski, J. C. Search for Related Content PubMed PubMed Citation Articles by Chang, W. Articles by Bulinski, J. C. Social Bookmarking                         What's this?

Phosphorylation of MAP4 affects microtubule properties and cell cycle progression

¹ Departments of Biological Sciences, Anatomy & Cell Biology, and Pathology, Colleges of Arts & Sciences and Physicians & Surgeons, Columbia University, 1212 Amsterdam Avenue, New York, NY 10027-2450, USA
² Integrated Program in Cell, Molecular & Biophysical Studies, College of Physicians & Surgeons, Columbia University, 1212 Amsterdam Avenue, New York, NY 10027-2450, USA
³ Department of Biological Sciences, Graduate School of Science, Tokyo Metropolitan University, 1-1 Minami-ohsawa, Hachiohji, Tokyo 192-0397, Japan
^* Author for correspondence (e-mail:jcb4{at}columbia.edu )

Accepted May 2, 2001

In human cells, MAP4, a microtubule-associated protein ubiquitously expressed in proliferating cells, has been shown to undergo in vivo phosphorylation. Two phosphorylation sites, serines 696 and 787, lie within the proline-rich region of its microtubule-binding domain. To test the hypothesis that phosphorylation at these sites influences microtubule properties or cell cycle progression, we prepared stable cell lines that inducibly express versions of MAP4 in which phosphorylation of these two serines was prevented by their replacement with alanine, lysine, or glutamate residues (AA-, KK-, or EE-MAP4). All non-phosphorylatable mutant forms of MAP4 expressed in mouse L^tk- cells were localized to MT arrays that were unremarkable in appearance. Expression of non-phosphorylatable mutants of MAP4 did not affect cell doubling time; however, expression of some mutants altered progression into or through cell division. Interactions of mutant MAP4 with MTs were examined in vitro. KK mutant MAP4 bound MTs more avidly than its wild-type counterpart, WT-MAP4. In vivo MT polymer also differed among the mutants: MTs in cells expressing the KK- and AA-MAP4 forms were more resistant to nocodazole depolymerization than those in cells expressing EE- or WT-MAP4 forms. Our results demonstrate that phosphorylation alters MAP4 properties and suggest a raison d'être for phosphorylation of the MAP4 microtubule-binding domain during cell cycle progression.

Key words: Phosphorylation, Microtubule binding, Microtubule dynamics, Stable microtubules, Mitosis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Qiang, W. Yu, A. Andreadis, M. Luo, and P. W. Baas Tau protects microtubules in the axon from severing by katanin. J. Neurosci., March 22, 2006; 26(12): 3120 - 3129. [Abstract] [Full Text] [PDF]

				M. Takahashi, H. Shiraishi, Y. Ishibashi, K. L. Blade, P. J. McDermott, D. R. Menick, D. Kuppuswamy, and G. Cooper IV Phenotypic consequences of {beta}1-tubulin expression and MAP4 decoration of microtubules in adult cardiocytes Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2072 - H2083. [Abstract] [Full Text] [PDF]

				P. Holmfeldt, G. Brattsand, and M. Gullberg Interphase and monoastral-mitotic phenotypes of overexpressed MAP4 are modulated by free tubulin concentrations J. Cell Sci., September 15, 2003; 116(18): 3701 - 3711. [Abstract] [Full Text] [PDF]

				L. A. Martello, P. Verdier-Pinard, H.-J. Shen, L. He, K. Torres, G. A. Orr, and S. B. Horwitz Elevated Levels of Microtubule Destabilizing Factors in a Taxol-resistant/dependent A549 Cell Line with an {alpha}-Tubulin Mutation Cancer Res., March 15, 2003; 63(6): 1207 - 1213. [Abstract] [Full Text] [PDF]